Bausch Health Cos Research and Development Expenses 2010-2024 | BHC

Bausch Health Cos research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Bausch Health Cos Annual Research and Development Expenses
(Millions of US $)
2023 $604
2022 $529
2021 $465
2020 $452
2019 $471
2018 $413
2017 $361
2016 $421
2015 $334
2014 $246
2013 $157
2012 $269
2011 $66
2010 $68
2009 $48
Bausch Health Cos Quarterly Research and Development Expenses
(Millions of US $)
2024-09-30 $146
2024-06-30 $156
2024-03-31 $151
2023-12-31 $152
2023-09-30 $153
2023-06-30 $156
2023-03-31 $143
2022-12-31 $142
2022-09-30 $133
2022-06-30 $127
2022-03-31 $127
2021-12-31 $117
2021-09-30 $121
2021-06-30 $115
2021-03-31 $112
2020-12-31 $119
2020-09-30 $103
2020-06-30 $108
2020-03-31 $122
2019-12-31 $114
2019-09-30 $123
2019-06-30 $117
2019-03-31 $117
2018-12-31 $120
2018-09-30 $107
2018-06-30 $94
2018-03-31 $92
2017-12-31 $90
2017-09-30 $81
2017-06-30 $94
2017-03-31 $96
2016-12-31 $174
2016-09-30 $20
2016-06-30 $124
2016-03-31 $103
2015-12-31 $-13
2015-09-30 $197
2015-06-30 $93
2015-03-31 $56
2014-12-31 $19
2014-09-30 $79
2014-06-30 $75
2014-03-31 $73
2013-12-31 $-69
2013-09-30 $173
2013-06-30 $29
2013-03-31 $24
2012-12-31 $210
2012-09-30 $19
2012-06-30 $18
2012-03-31 $22
2011-12-31 $17
2011-09-30 $17
2011-06-30 $18
2011-03-31 $14
2010-12-31 $18
2010-09-30 $14
2010-06-30 $24
2010-03-31 $13
2009-12-31 $-35
2009-09-30 $23
2009-06-30 $45
2009-03-31 $15
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.012B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00